About Us
Founded in 2009, Flagship Biosciences, Inc., is a technology-driven spatial biology and biomarker services company delivering the most accurate and informative data available.
We are revolutionizing biomarker analysis to improve drug development and diagnostics using the power of AI with a consultative approach. Our services and technology improve on the data and interpretation from traditional methods, eliminating variability associated with typical biomarker assessments, and bringing new insights to analysis results. We provide expert scientific consultation for every client. Our team interprets results, contextualizes biology, and identifies the best course for success.
Leadership Team
Michael Boezer, M.B.A.
Chief Financial Officer
Thomas Turi, Ph.D.
Chief Executive Officer
Roberto Gianani, M.D.
Chief Medical OfficerPARTNERSHIPS
Flagship Biosciences operates at the forefront of innovation, forging strategic alliances with pioneers in drug development, spatial biology and multiomics to deliver unparalleled services to our clients. By collaborating with cutting-edge leaders in these fields, we harness the power of new technologies and methods (including spatially resolved molecular data and multiomics approaches) to provide comprehensive insights into complex biological systems. Our partnerships enable us to ensure that we deliver the highest quality solutions tailored to the unique needs of each client. Through these collaborations, Flagship Biosciences remains committed to driving advancements in precision medicine and empowering our clients with the most advanced tools for scientific discovery and therapeutic development.
